Ren, H., Lin, L., Shen, P., Li, X., Xie, J., Pan, X., . . . Chen, N. (2017). Rituximab treatment in adults with refractory minimal change disease or focal segmental glomerulosclerosis. Oncotarget.
Citação norma ChicagoRen, Hong, Li Lin, Pingyan Shen, Xiao Li, Jingyuan Xie, Xiaoxia Pan, Wen Zhang, and Nan Chen. "Rituximab Treatment in Adults With Refractory Minimal Change Disease or Focal Segmental Glomerulosclerosis." Oncotarget 2017.
ציטוט MLARen, Hong, et al. "Rituximab Treatment in Adults With Refractory Minimal Change Disease or Focal Segmental Glomerulosclerosis." Oncotarget 2017.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.